10 /100
LOW RISK
Score updated Jul 13, 2026

EW — Edwards Lifesciences Corporation Dilution Risk Tracker

Track EW dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EW — Get alerts when the score changes →

As of July 13, 2026, Edwards Lifesciences Corporation (EW) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Edwards Lifesciences Corporation has a market capitalization of $49.79B, 575.80M shares outstanding, 1296 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
19
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for EW.
🔔 Track EW — Get forecast alerts →

💹 Market Data

Market Cap$49.79B
Shares Outstanding575.80M
Float573.99M
Cash$3.67B
Debt$598.50M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.4% shares (2026Q1 vs prior)
1296 institutional holders · 584.78M shares
#1 BlackRock, Inc. 52.73M shares
#2 DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 38.50M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 37.73M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest11.47M
Days to Cover2.1
% of Float2.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2008
4 INSIDER TRANSACTION May 04, 2026
4 INSIDER TRANSACTION May 04, 2026
4 INSIDER TRANSACTION May 04, 2026
4 INSIDER TRANSACTION Apr 09, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for EW Shareholders

Edwards Lifesciences Corporation (EW) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for EW shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for EW in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for EW alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track EW Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EW — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for EW
📊 EW FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 EW Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.